US Edition
Prevail DCB gains expanded CE mark indications - Cardiovascular News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Prevail DCB gains expanded CE mark indications - Cardiovascular News
Medtronic has received CE mark approval for several expanded indications for the treatment of coronary artery disease (CAD) with the Prevail paclitaxel-coated percutaneous transluminal coronary angioplasty (PTCA) balloon catheter, or drug-coated balloon (DCB). The Prevail DCB now has the broadest range of CE Mark indications including bifurcation and is the only DCB indicated for treatment in patients with multivessel disease, acute coronary syn…
Medtronic earns expanded CE mark for Prevail drug-coated balloon
The Medtronic Prevail drug coated balloon [Image courtesy of Medtronic]Medtronic announced today that it received CE mark for several expanded indications for its Prevail balloon catheter. The expanded indications for the paclitaxel-coated percutaneous transluminal coronary angioplasty (PTCA) balloon catheter (or drug-coated balloon/DCB) cover the treatment of coronary artery disease (CAD). According to the medtech giant, Prevail now has the bro…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
